AKT1 and hepatocellular carcinoma: Hu et al. discovered that Akt signaling was able to enhance the efflux activity of side population (SP) cells via altering the subcellular localization and distribution of ABC transporter (known to confer drug resistance) in HCC cell line MHCC-97L [111].